These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16012920)

  • 1. [Effect of botulinum toxin a and B on vegetative cardiac innervation].
    Meichsner M; Reichel G
    Fortschr Neurol Psychiatr; 2005 Jul; 73(7):409-14. PubMed ID: 16012920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
    Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
    Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
    [No Abstract]   [Full Text] [Related]  

  • 5. Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.
    Tintner R; Gross R; Winzer UF; Smalky KA; Jankovic J
    Neurology; 2005 Sep; 65(5):765-7. PubMed ID: 16157918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure.
    Dressler D; Bigalke H; Benecke R
    J Neurol; 2003 Aug; 250(8):967-9. PubMed ID: 12928917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
    J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of botulinum toxin therapies.
    Madalinski MH; Slawek J
    Dis Colon Rectum; 2003 Dec; 46(12):1719-20. PubMed ID: 14668605
    [No Abstract]   [Full Text] [Related]  

  • 12. Autonomic side effects of botulinum toxin type B therapy.
    Dressler D; Benecke R
    Adv Neurol; 2004; 94():315-20. PubMed ID: 14509689
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.
    Naidu K; Smith K; Sheedy M; Adair B; Yu X; Graham HK
    Dev Med Child Neurol; 2010 Feb; 52(2):139-44. PubMed ID: 20412252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
    Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.
    Kranz G; Sycha T; Voller B; Gleiss A; Schnider P; Auff E
    Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin: influence on respiratory heart rate variation.
    Claus D; Druschky A; Erbguth F
    Mov Disord; 1995 Sep; 10(5):574-9. PubMed ID: 8552108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ptosis as a remote effect of therapeutic botulinum toxin B injection.
    Racette BA; Lopate G; Good L; Sagitto S; Perlmutter JS
    Neurology; 2002 Nov; 59(9):1445-7. PubMed ID: 12427903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
    Langdon K; Blair E; Davidson SA; Valentine J
    Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
    Chan KH; Liang C; Wilson P; Higgins D; Allen GC
    JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.